Results 161 to 170 of about 487,201 (201)
Some of the next articles are maybe not open access.

POLYCYTHEMIA VERA AND GLOMERULONEPHRITIS

Australian and New Zealand Journal of Medicine, 1983
Abstract: Six patients with polycythemia vera and proteinuria are described. Three patients had histologically defined glomerulonephritis. It is proposed that there is an association between polycythemia vera and the development of glomerulonephritis. Possible pathogenetic mechanisms are discussed.
R F, Plomley   +5 more
openaire   +2 more sources

The treatment of polycythemia vera

Journal of Chronic Diseases, 1957
p” LYCYTHEMIA vera is a chronic disease of unknown etiology, the chief clinical manifestations of which are headaches, fatigability, dizziness, pruritus, splenomegaly, plethora, cyanosis, and systolic hypertension. Elevations of the erythrocyte level, the hemoglobin concentration, and the hematocrit value constitute the most consistent laboratory ...
E H, REINHARD, B, HAHNEMAN
openaire   +2 more sources

Apoptosis and polycythemia vera

Current Opinion in Hematology, 1999
Polycythemia vera is an acquired clonal myeloproliferative disorder characterized by increased numbers of erythroid cells, often with a concomitant rise in neutrophils and/or megakaryocytes. Normally, erythropoietin is essential for the survival and proliferation of erythroid progenitors; however in polycythemia vera the erythroid progenitor cells can ...
openaire   +2 more sources

The Hypercoagulability of Polycythemia Vera

Hospital Practice, 1993
Thrombosis is the most common cause of death in patients with this myeloproliferative syndrome. Phlebotomy, hydroxyurea, and antiplatelet agents are the mainstays of therapy but may not stave off a lethal embolism.
W, Fields, N J, Freeman
openaire   +2 more sources

Polycythemia Vera in Dogs

Journal of the American Veterinary Medical Association, 1974
SUMMARY The historical and laboratory findings in 5 published reports and 3 additional cases of polycythemia vera in the dog were reviewed. The consistent abnormal findings included increased packed cell volume (pcv), hemoglobin concentration, red blood cell (rbc) count, rbc mass, and total blood volume.
openaire   +2 more sources

Anesthesia for polycythemia vera

Journal of Clinical Anesthesia, 1990
Cystoscopy was postponed on an 80-year-old male found to have a hematocrit of 57%. After the diagnosis of polycythemia vera was made, he was phlebotomized and treated with hydroxyurea. He was readmitted 2 months later for transurethral resection of the prostate. After the induction of general endotracheal anesthesia with thiopental and succinylcholine,
openaire   +2 more sources

Polycythemia Vera: A Review

Clinical Journal of Oncology Nursing, 2003
Polycythemia vera (PV) is a clonal stem cell disorder characterized by increased erythrocyte production. Its etiology is not fully understood, and hemorrhage, thrombosis, and hyperviscosity may occur at any time during the course of this disorder. Treatment depends on the most affected cell type, duration and severity of the condition, and patient age.
openaire   +2 more sources

POLYCYTHEMIA VERA IN CHILDHOOD

Archives of Pediatrics & Adolescent Medicine, 1972
To the Editor.—The recent communication by Natelson et al1at the first glance appears to add another report to the compendium of chromosomal abnormalities, specific or nonspecific, as the case may be. The nonspecific chromosomal abnormalities probably are not significant since they may not have any relation to the clinical nature or etiology of the ...
openaire   +2 more sources

Treatment of Polycythemia Vera

Seminars in Thrombosis and Hemostasis, 2006
The selection of treatment for patients with polycythemia vera (PV) still is the subject of much discussion among hematologists. It is emphasized that important physiologic and pathogenic components of the illness relate not only to the erythroid cell, but also to the megakaryocyte.
openaire   +2 more sources

Polycythemia vera and other primary polycythemias

Current Opinion in Hematology, 2005
Diagnosis and therapy of polycythemia vera are controversial since the molecular basis of polycythemia vera remains unknown. Distinguishing between polycythemia vera and other polycythemic disorders can be very challenging. The purpose of this review is to discuss the recent progress in this area and critically review the published data in context of ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy